ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

Columbia To Host U.S.- China Conference

February 15, 1980

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

In Brief: Two Major Appointments Made At Fox Chase; HHS Names Task Force to Look At DRG Research Impact

April 20, 1984

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996